Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months. 1990

D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
Praxis Biologics, Inc., Rochester, NY 14623-1493.

A total of 268 infants aged 15 to 23 months received one dose of a vaccine composed of Haemophilus influenzae type b oligosaccharides covalently linked to the nontoxic diphtheria toxin variant CRM197 (HbOC; HibTITER). Side effects associated with vaccination were infrequent, transient, and mild. One month after a single vaccination, the anti-H influenzae type b capsular polysaccharide antibody concentration rose from a geometric mean prevaccination level of 0.20 microgram/mL to 13.77 micrograms/mL. Of these infants, 99% had a postvaccination level greater than or equal to 1.00 microgram/mL, a level associated with long-term protection. The immune response was long-lived: all of the children who were monitored 17 to 27 months after vaccination had concentrations greater than or equal to 1.00 microgram/mL. The anti-H influenzae type b capsular polysaccharide antibody generated was predominantly of the IgG isotype and IgG1 subclass. The immune sera had bactericidal activity in vitro and conferred passive protection in the infant rat meningitis model.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
February 1985, The Journal of pediatrics,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
June 2003, Pediatrics international : official journal of the Japan Pediatric Society,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
June 1993, The Pediatric infectious disease journal,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
February 1998, Tropical medicine & international health : TM & IH,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
September 1997, Indian pediatrics,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
January 1994, Annals of tropical paediatrics,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
August 1991, The Pediatric infectious disease journal,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
December 2004, Infection and immunity,
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
August 1993, American journal of diseases of children (1960),
D V Madore, and C L Johnson, and D C Phipps, and M G Myers, and R Eby, and D H Smith
October 1987, The Journal of infectious diseases,
Copied contents to your clipboard!